Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis
Messoud Ashina*, Dimos D Mitsikostas, Verena Ramirez Campos, Steve Barash, Xiaoping Ning, Hans-Christoph Diener
Dive into the research topics of 'Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis'. Together they form a unique fingerprint.
Medicine and Dentistry
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science